Skip to Main Content

Paper Details

Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
J Clin Oncol
50
2022
AALL0434, AALL1231, Bortezomib, Children, Lymphoma, Patients, T, T-ALL, T-Cell Acute Lymphoblastic Leukemia, T-LL, T-cell acute lymphoblastic leukemia, bortezomib, dexamethasone, lymphoblastic lymphoma, patients, pegaspargase, prednisone
Author NameAffiliation
Meenakshi DevidasSt Jude Children's Research Hospital
Mignon L LohBenioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Stephen P HungerDepartment of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and The Perelman School of Medicine at The University of Pennsylvania
Stephen P HungerDepartment of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and The Perelman School of Medicine at The University of Pennsylvania
  • 1 - 4

Datasets

Release 1.2